185 related articles for article (PubMed ID: 36172919)
21. miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.
Bar J; Gorn-Hondermann I; Moretto P; Perkins TJ; Niknejad N; Stewart DJ; Goss GD; Dimitroulakos J
Clin Lung Cancer; 2015 Nov; 16(6):e121-9. PubMed ID: 25703099
[TBL] [Abstract][Full Text] [Related]
22. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
[TBL] [Abstract][Full Text] [Related]
23. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
24. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
Tan Z; Cao F; Jia B; Xia L
Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of miR-1290 contributes to cell proliferation and invasion of non small cell lung cancer by targeting interferon regulatory factor 2.
Jin JJ; Liu YH; Si JM; Ni R; Wang J
Int J Biochem Cell Biol; 2018 Feb; 95():113-120. PubMed ID: 29275213
[TBL] [Abstract][Full Text] [Related]
26. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial creatine kinase 1 regulates the cell cycle in non-small cell lung cancer via activation of cyclin-dependent kinase 4.
Yang M; Wang X; Ye Z; Liu T; Meng Y; Duan Y; Yuan X; Yue X; Deng W; Liu RY
Respir Res; 2023 Apr; 24(1):111. PubMed ID: 37061730
[TBL] [Abstract][Full Text] [Related]
28. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
Cui D; Qian R; Li Y
Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
[TBL] [Abstract][Full Text] [Related]
29. PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer.
Xiong S; Zheng Y; Jiang P; Liu R; Liu X; Qian J; Gu J; Chang L; Ge D; Chu Y
Br J Cancer; 2014 Jan; 110(2):353-62. PubMed ID: 24281003
[TBL] [Abstract][Full Text] [Related]
30. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
[TBL] [Abstract][Full Text] [Related]
31. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
Huang RS; Zheng YL; Zhao J; Chun X
Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202
[TBL] [Abstract][Full Text] [Related]
32. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
Liu L; Chen Y; Li Q; Duan P
J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
[TBL] [Abstract][Full Text] [Related]
33. Quaking orchestrates a post-transcriptional regulatory network of endothelial cell cycle progression critical to angiogenesis and metastasis.
Azam SH; Porrello A; Harrison EB; Leslie PL; Liu X; Waugh TA; Belanger A; Mangala LS; Lopez-Berestein G; Wilson HL; McCann JV; Kim WY; Sood AK; Liu J; Dudley AC; Pecot CV
Oncogene; 2019 Jun; 38(26):5191-5210. PubMed ID: 30918328
[TBL] [Abstract][Full Text] [Related]
34. Long Noncoding RNA SNHG6 Promotes Proliferation and Inhibits Apoptosis in Non-small Cell Lung Cancer Cells by Regulating miR-490-3p/RSF1 Axis.
Dong Z; Liu H; Zhao G
Cancer Biother Radiopharm; 2020 Jun; 35(5):351-361. PubMed ID: 32202941
[No Abstract] [Full Text] [Related]
35. miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression.
Li S; Wang C; Yu X; Wu H; Hu J; Wang S; Ye Z
Oncol Rep; 2017 Jan; 37(1):241-248. PubMed ID: 27878260
[TBL] [Abstract][Full Text] [Related]
36. [Effect of synthetic small double-stranded RNA on the development of bladder cancer by activating P21 expression].
Ge Q; Wang C; Chen Z; Zhang Q; Yang W; Ye Z
Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(10):812-6. PubMed ID: 27055644
[TBL] [Abstract][Full Text] [Related]
37. A novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulating miR-99a/mTOR signaling.
Song Y; Dou H; Wang P; Zhao S; Wang T; Gong W; Zhao J; Li E; Tan R; Hou Y
Cancer Biol Ther; 2014 Oct; 15(10):1423-30. PubMed ID: 25046358
[TBL] [Abstract][Full Text] [Related]
38. Linc00703 suppresses non-small cell lung cancer progression by modulating CyclinD1/CDK4 expression.
Sun HB; Han XL; Zhong M; Yu DJ
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6131-6138. PubMed ID: 32572878
[TBL] [Abstract][Full Text] [Related]
39. miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2.
Lang B; Zhao S
Oncol Rep; 2018 Jan; 39(1):71-80. PubMed ID: 29115564
[TBL] [Abstract][Full Text] [Related]
40. [siRNA-mediated CDK6 knockdown suppresses nasopharyngeal carcinoma cell growth and cell cycle transition in vitro].
Luo X; Xia Q; Qin J; Huang Y; Liu J; Wang Y; Wang H; Chen J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):1071-4. PubMed ID: 25057088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
